OCULAR THERAPEUTIX, INC Capital Expenditures
OCULAR THERAPEUTIX, INC (OCUL) reported Capital Expenditures of $8.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-03
- OCULAR THERAPEUTIX, INC payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $3.37M, a 170.44% increase year-over-year.
- OCULAR THERAPEUTIX, INC payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $4.66M, a 141.18% increase year-over-year.
- OCULAR THERAPEUTIX, INC payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $2.84M, a 1305.45% increase year-over-year.
- OCULAR THERAPEUTIX, INC payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $5.99M, a 6633.71% increase year-over-year.
- OCULAR THERAPEUTIX, INC payments to acquire property, plant, and equipment for fiscal 2025 was $12.01M, a 832.45% increase from fiscal 2024.
- OCULAR THERAPEUTIX, INC payments to acquire property, plant, and equipment for fiscal 2024 was $1.29M, a 78.84% decline from fiscal 2023.
- OCULAR THERAPEUTIX, INC payments to acquire property, plant, and equipment for fiscal 2023 was $6.09M, a 63.85% increase from fiscal 2022.
- OCULAR THERAPEUTIX, INC payments to acquire property, plant, and equipment for fiscal 2022 was $3.71M, a 211.14% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $8.03M 10-Q · filed 2026-08-03 | $10.87M derived: sum of 3 quarters · filed 2026-08-03 | $16.86M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $4.66M 10-Q · filed 2026-05-05 | $7.50M derived: sum of 2 quarters · filed 2026-05-05 | $13.49M derived: sum of 3 quarters · filed 2026-05-05 | $14.74M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $8.83M derived: sum of 2 quarters · filed 2026-02-05 | $10.08M derived: sum of 3 quarters · filed 2026-08-03 | $12.01M 10-K · filed 2026-02-05 |
| 2025-09-30 | $5.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.24M derived: sum of 2 quarters · filed 2026-08-03 | $9.17M 10-Q · filed 2025-11-04 | $9.37M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $3.18M 10-Q · filed 2026-08-03 | $3.38M derived: sum of 3 quarters · filed 2026-08-03 | $3.47M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $1.93M 10-Q · filed 2026-05-05 | $2.13M derived: sum of 2 quarters · filed 2026-05-05 | $2.22M derived: sum of 3 quarters · filed 2026-05-05 | $2.97M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $291.00K derived: sum of 2 quarters · filed 2026-02-05 | $1.03M derived: sum of 3 quarters · filed 2026-02-05 | $1.29M 10-K · filed 2026-02-05 |
| 2024-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $831.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.09M 10-Q · filed 2025-11-04 | $1.54M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-06-30 | $742.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $997.00K 10-Q · filed 2025-08-05 | $1.46M derived: sum of 3 quarters · filed 2026-02-05 | $1.72M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-03-31 | $255.00K 10-Q · filed 2025-05-05 | $714.00K derived: sum of 2 quarters · filed 2026-02-05 | $973.00K derived: sum of 3 quarters · filed 2026-02-05 | $2.96M derived: sum of 4 quarters · filed 2026-02-05 |
| 2023-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | $718.00K derived: sum of 2 quarters · filed 2026-02-05 | $2.71M derived: sum of 3 quarters · filed 2026-02-05 | $6.09M 10-K · filed 2026-02-05 |
| 2023-09-30 | $259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.25M derived: sum of 2 quarters · filed 2024-11-14 | $5.63M 10-Q · filed 2024-11-14 | $7.78M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.37M 10-Q · filed 2024-08-07 | $7.52M derived: sum of 3 quarters · filed 2025-03-03 | $8.31M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $3.38M 10-Q · filed 2024-05-07 | $5.53M derived: sum of 2 quarters · filed 2025-03-03 | $6.32M derived: sum of 3 quarters · filed 2025-03-03 | $6.82M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.94M derived: sum of 2 quarters · filed 2025-03-03 | $3.44M derived: sum of 3 quarters · filed 2025-03-03 | $3.71M 10-K · filed 2025-03-03 |
| 2022-09-30 | $794.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.29M derived: sum of 2 quarters · filed 2023-11-07 | $1.56M 10-Q · filed 2023-11-07 | $2.20M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $495.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $771.00K 10-Q · filed 2023-08-07 | $1.40M derived: sum of 3 quarters · filed 2024-03-11 | $1.68M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | $276.00K 10-Q · filed 2023-05-08 | $907.00K derived: sum of 2 quarters · filed 2024-03-11 | $1.18M derived: sum of 3 quarters · filed 2024-03-11 | $1.31M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $631.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $907.00K derived: sum of 2 quarters · filed 2024-03-11 | $1.04M derived: sum of 3 quarters · filed 2024-03-11 | $1.19M 10-K · filed 2024-03-11 |
| 2021-09-30 | $276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $405.00K derived: sum of 2 quarters · filed 2022-11-07 | $563.00K 10-Q · filed 2022-11-07 | $816.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $287.00K 10-Q · filed 2022-08-08 | $540.00K derived: sum of 3 quarters · filed 2023-03-06 | $754.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $158.00K 10-Q · filed 2022-05-09 | $411.00K derived: sum of 2 quarters · filed 2023-03-06 | $625.00K derived: sum of 3 quarters · filed 2023-03-06 | $750.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $467.00K derived: sum of 2 quarters · filed 2023-03-06 | $592.00K derived: sum of 3 quarters · filed 2023-03-06 | $841.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $339.00K derived: sum of 2 quarters · filed 2021-11-08 | $588.00K 10-Q · filed 2021-11-08 | $1.19M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $374.00K 10-Q · filed 2021-08-09 | $975.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.39M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $249.00K 10-Q · filed 2021-05-05 | $850.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.27M derived: sum of 3 quarters · filed 2022-02-28 | $1.76M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.02M derived: sum of 2 quarters · filed 2022-02-28 | $1.51M derived: sum of 3 quarters · filed 2022-02-28 | $2.24M 10-K · filed 2022-02-28 |
| 2019-09-30 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $912.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.64M 10-Q · filed 2020-11-05 | $2.12M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $493.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.22M 10-Q · filed 2020-08-07 | $1.70M derived: sum of 3 quarters · filed 2020-08-07 | $2.17M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $725.00K 10-Q · filed 2020-05-08 | $1.20M derived: sum of 2 quarters · filed 2020-05-08 | $1.68M derived: sum of 3 quarters · filed 2020-05-08 | $2.23M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $479.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $952.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.51M derived: sum of 3 quarters · filed 2020-03-12 | $1.89M 10-K · filed 2020-03-12 |
| 2018-09-30 | $473.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.03M derived: sum of 2 quarters · filed 2019-11-12 | $1.41M 10-Q · filed 2019-11-12 | $1.97M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $556.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $937.00K 10-Q · filed 2019-08-07 | $1.50M derived: sum of 3 quarters · filed 2020-03-12 | $3.54M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $381.00K 10-Q · filed 2019-05-10 | $945.00K derived: sum of 2 quarters · filed 2020-03-12 | $2.98M derived: sum of 3 quarters · filed 2020-03-12 | $6.98M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $564.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.60M derived: sum of 2 quarters · filed 2020-03-12 | $6.60M derived: sum of 3 quarters · filed 2020-03-12 | $8.25M 10-K · filed 2020-03-12 |
| 2017-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $6.03M derived: sum of 2 quarters · filed 2018-11-07 | $7.69M 10-Q · filed 2018-11-07 | $8.37M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $5.65M 10-Q · filed 2018-08-07 | $6.33M derived: sum of 3 quarters · filed 2019-03-07 | $7.20M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $1.65M 10-Q · filed 2018-05-08 | $2.33M derived: sum of 2 quarters · filed 2019-03-07 | $3.20M derived: sum of 3 quarters · filed 2019-03-07 | $3.45M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $680.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.55M derived: sum of 2 quarters · filed 2019-03-07 | $1.79M derived: sum of 3 quarters · filed 2019-03-07 | $1.92M 10-K · filed 2019-03-07 |
| 2016-09-30 | $869.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.11M derived: sum of 2 quarters · filed 2017-11-07 | $1.24M 10-Q · filed 2017-11-07 | $1.71M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $370.00K 10-Q · filed 2017-08-08 | $843.00K derived: sum of 3 quarters · filed 2018-03-08 | $919.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $127.00K 10-Q · filed 2017-05-05 | $600.00K derived: sum of 2 quarters · filed 2018-03-08 | $676.00K derived: sum of 3 quarters · filed 2018-03-08 | $1.55M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $549.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.42M derived: sum of 3 quarters · filed 2018-03-08 | $1.78M 10-K · filed 2018-03-08 |
| 2015-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $951.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.30M 10-Q · filed 2016-11-09 | $1.75M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $875.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.23M 10-Q · filed 2016-08-09 | $1.67M derived: sum of 3 quarters · filed 2017-03-10 | $1.94M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $354.00K 10-Q · filed 2016-05-10 | $795.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.07M derived: sum of 3 quarters · filed 2017-03-10 | $1.32M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $715.00K derived: sum of 2 quarters · filed 2017-03-10 | $963.00K derived: sum of 3 quarters · filed 2017-03-10 | $1.26M 10-K · filed 2017-03-10 |
| 2014-09-30 | $274.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $522.00K derived: sum of 2 quarters · filed 2015-11-10 | $819.00K 10-Q · filed 2015-11-10 | $1.02M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $545.00K 10-Q · filed 2015-08-10 | $751.00K derived: sum of 3 quarters · filed 2016-03-10 | $860.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $297.00K 10-Q · filed 2015-05-15 | $503.00K derived: sum of 2 quarters · filed 2016-03-10 | $612.00K derived: sum of 3 quarters · filed 2016-03-10 | |
| 2013-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $315.00K derived: sum of 2 quarters · filed 2016-03-10 | $387.00K 10-K · filed 2016-03-10 | |
| 2013-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $181.00K 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $72.00K 10-Q · filed 2014-08-29 | |||
| 2012-12-31 | $203.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |